Federally funded research contributed to the science underlying all new medicines approved by the FDA over the past six years, according to a new study by Bentley University. The new report from the Center for Integration of Science and Industry at Bentley University, published in the Proceedings of the National Academy of Sciences, shows that…
Thirty Years of Innovation Pays Off as Oligonucleotide Therapeutics Come to Market
The recent approval of Spinraza (nusinersen), jointly developed by Ionis Pharmaceuticals and Biogen, marks the arrival of a new class of biological products – oligonucleotide therapeutics. A recent publication from the Center for Integration of Science and Industry at Bentley University shows that the thirty year path from the initiation of research on oligonucleotides as therapeutics to…